Fortress Revenue Per Share from 2010 to 2024
| FBIO Stock | USD 1.72 0.02 1.15% |
Revenue Per Share | First Reported 2010-12-31 | Previous Quarter 10.41967445 | Current Value 16.95 | Quarterly Volatility 16.79090777 |
Check Fortress Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fortress Biotech's main balance sheet or income statement drivers, such as Interest Expense of 6.5 M, Selling General Administrative of 104.7 M or Research Development of 59.7 M, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.38 or PTB Ratio of 1.03. Fortress financial statements analysis is a perfect complement when working with Fortress Biotech Valuation or Volatility modules.
Fortress | Revenue Per Share |
Latest Fortress Biotech's Revenue Per Share Growth Pattern
Below is the plot of the Revenue Per Share of Fortress Biotech over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Fortress Biotech's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fortress Biotech's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.15 | 10 Years Trend |
|
Revenue Per Share |
| Timeline |
Fortress Revenue Per Share Regression Statistics
| Arithmetic Mean | 10.49 | |
| Geometric Mean | 2.99 | |
| Coefficient Of Variation | 160.10 | |
| Mean Deviation | 9.06 | |
| Median | 9.28 | |
| Standard Deviation | 16.79 | |
| Sample Variance | 281.93 | |
| Range | 67.2124 | |
| R-Value | 0.32 | |
| Mean Square Error | 272.17 | |
| R-Squared | 0.10 | |
| Significance | 0.24 | |
| Slope | 1.21 | |
| Total Sum of Squares | 3,947 |
Fortress Revenue Per Share History
About Fortress Biotech Financial Statements
Fortress Biotech investors utilize fundamental indicators, such as Revenue Per Share, to predict how Fortress Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Revenue Per Share | 10.42 | 16.95 |
Pair Trading with Fortress Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Fortress Stock
| 0.66 | DMAC | DiaMedica Therapeutics Upward Rally | PairCorr |
Moving against Fortress Stock
| 0.59 | VINC | Vincerx Pharma | PairCorr |
| 0.5 | DTIL | Precision BioSciences | PairCorr |
| 0.48 | ME | 23Andme Holding | PairCorr |
| 0.48 | VALN | Valneva SE ADR | PairCorr |
| 0.42 | DNLI | Denali Therapeutics Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Fortress Biotech Correlation against competitors. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.